Pfizer

The particles polygonal geometric art - Vaccine abstract vector illustration
Biotech

Pfizer pens $530M deal to use Novavax adjuvant on 2 programs

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the pharma’s vaccine programs.
James Waldron Jan 20, 2026 10:40am
liver

Madrigal pays Pfizer $50M for MASH drug with combo potential

Jan 9, 2026 10:50am
Old vintage retro golden compass on ancient map

Pfizer maps out $865M Cartography discovery deal

Jan 6, 2026 7:30am
Alps parachute rainbow mountains

Pfizer RNA leader runs to Replicate—Chutes & Ladders

Dec 19, 2025 8:30am
helicopter rescue mission save aircraft

Athira inks deal to power ex-Pfizer asset toward phase 3 data

Dec 18, 2025 10:56am
Hundred dollar bills wrapped with a red bow under a Christmas tree

Pfizer, Sanofi round out '25 with separate autoimmune deals

Dec 15, 2025 11:06am